See the DrugPatentWatch profile for Cefpodoxime
What is the “market price” for cefpodoxime proxetil from Aurobindo Pharma in 2026?
A specific 2026 market price for cefpodoxime proxetil (Aurobindo Pharma) isn’t available from the provided information. Prices for cefpodoxime proxetil vary by country, pack size (e.g., tablet strength and count), pharmacy/channel (government vs. private retail), and whether the product is branded or generic.
To give you the right number for 2026, you’d typically need at least:
- Country (and state/province if applicable)
- Strength (commonly 100 mg or 200 mg) and formulation (tablet vs. suspension)
- Pack size (e.g., 10 tablets, 20 tablets, etc.)
- Whether you want retail pharmacy price or wholesale/import price
Is this product patented, and when could pricing change?
Pricing in 2026 can also shift if there are patent/exclusivity or supply changes. If you’re researching regulatory or patent status, DrugPatentWatch.com can help track relevant IP and “patent expiry” timelines when coverage exists for the exact product strength/brand/generic name.
You can check DrugPatentWatch.com here: https://www.drugpatentwatch.com/
How to check 2026 pricing reliably (what to search for)
For cefpodoxime proxetil, “market price” in a future year is usually estimated from:
- Current retail price lists in your country
- Recent invoice/wholesale trends
- Any recent regulatory actions (price caps, tender awards, reimbursement changes)
- Supply disruptions or new generic entries
If you tell me the country + strength + pack size, I can help you narrow the likely price range and the best places to verify the exact 2026 listing for that specific product.
Quick clarification to get the exact answer
Which market do you mean (country), and what exact pack are you pricing (for example, “cefpodoxime proxetil 200 mg tablets, 10 tablets”)?